Imatinib Plasma Monitoring-Guided Dose Modification for Managing Imatinib-Related Toxicities in Gastrointestinal Stromal Tumor Patients

Imatinib, the first-line treatment in patients with advanced gastrointestinal stromal tumors (GIST), is generally well tolerated, although some patients have difficulty tolerating the standard dose of 400 mg/day. Adjusting imatinib dosage by plasma level monitoring may facilitate management of patie...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Yoon, Shinkyo, Ryu, Min-Hee, Yoo, Changhoon, Beck, Mo Youl, Ryoo, Baek-Yeol, Kang, Yoon-Koo
格式: Artigo
語言:Inglês
出版: The Korean Academy of Medical Sciences 2013
主題:
Case Report
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3744717/
https://ncbi.nlm.nih.gov/pubmed/23960456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2013.28.8.1248
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍